The pancreatic cancer treatment market is estimated to increase from US3.16 Bn in 2024 to US$9.28 Bn by 2031. The market is projected to record a healthy CAGR of 16.6% during the forecast period from 2024 to 2031. Pancreatic cancer cases are increasing due to unhealthy diets, heavy industrialization, and chemical exposure. The market is growing due to the collaborative research and development efforts are essential for new therapies.